/
NSB.AX
No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Biotechnology
NeuroScientific Biopharmaceuticals Limited
Established in 2002 and headquartered in Cottesloe, Australia, NeuroScientific Biopharmaceuticals Limited specializes in the development of medical therapies for neurodegenerative conditions. The company conducts extensive preclinical and clinical research utilizing its proprietary technological platforms to advance these treatments. Its primary pharmaceutical compound, EmtinB, is being developed as a potential therapeutic agent for diseases including neurodegenerative dementia, Alzheimer's disease, and various degenerative disorders affecting the optic nerve.
www.neuroscientific.com- Employees
- 9
- IPO / List date
- Jul 27, 2018
- HQ
- AU
Held by traders on TradeandTell
No one on the platform currently holds NSB.AX.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in NSB.AX as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded NSB.AX yet.